Bolt Biotherapeutics (BOLT) Receivables - Other (2023 - 2025)
Bolt Biotherapeutics' Receivables - Other history spans 2 years, with the latest figure at $1.2 million for Q4 2024.
- For Q4 2024, Receivables - Other fell 23.71% year-over-year to $1.2 million; the TTM value through Dec 2024 reached $1.2 million, down 23.71%, while the annual FY2024 figure was $1.2 million, 23.71% down from the prior year.
- Receivables - Other for Q4 2024 was $1.2 million at Bolt Biotherapeutics, down from $1.5 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.5 million in Q4 2023 and bottomed at $1.2 million in Q4 2024.